| Title | Linear scleroderma in children. | | Author(s) | Eubanks LE, McBurney EI, Galen W, Reed R | | Institution | Department of Dermatology, Tulane University School of Medicine, New Orleans, Louisiana, USA. | | Source | Int J Dermatol 1996 May; 35(5):330-6. | | MeSH | Administration, Topical
Adolescent
Anti-Infective Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Aspirin
Betamethasone
Child
Dermatologic Agents
Drug Therapy, Combination
Female
Glucocorticoids
Humans
Male
Methylprednisolone
Penicillins
Phenytoin
Scleroderma, Localized
Ticlopidine
Vitamin E
| | Abstract | BACKGROUND. Linear scleroderma is a cutaneous disease of unknown etiology. It most often affects children, who develop band-like lesions in an asymmetric distribution. The literature is reviewed as to the diagnosis, pathogenesis, and treatment of linear scleroderma. CASE REPORT. Six new cases of linear scleroderma in children are reported. Their ages ranged from 6 to 17 years, and five were girls. A 17-year-old girl had en coup de sabre. Multiple treatment modalities were used. All laboratory testing was negative.
CONCLUSIONS. Linear scleroderma is a clinical diagnosis. The pathogenesis remains unknown. A consistently effective therapy has not been found, although diphenylhydantoin and ticlopidine hydrochloride should be evaluated in clinical trials. | | Language | eng | | Pub Type(s) | Case Reports
Journal Article
Review
| | PubMed ID | 8734654 |
|
